Essential Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Essential Partners's RMD Position: Q3 2026 in Review
Essential Partners reduced its ResMed (RMD) stake by 7.1% in Q3 2026, selling an estimated $2.62K and leaving 156 shares worth $34.5K. The position accounts for 0.02% of the portfolio, ranked #735.
Essential Partners first reported a position in RMD in Q2 2025 and has held it in 6 quarters since. 167 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Essential Partners held 156 shares of ResMed worth $34.5K as of Q3 2026.
- Essential Partners sold 12 ResMed shares in Q3 2026, an estimated $2.62K.
- ResMed made up 0.02% of Essential Partners's portfolio in Q3 2026, its #735 holding.
- Essential Partners first reported a position in ResMed in Q2 2025 and has held it in 6 quarters since.
- 167 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.